Skip to content
Baker Capital StrategiesMARKETS. FILINGS. PERSPECTIVE.
Powered by THEMA

Baker Capital Strategies

Free Registration

Register for access to news, tools, alerts and reports.

THEMA Basic included at launch.

Use at least 8 characters.

SEC Filing · 6-K

Evogene Ltd

EVGNNASDAQEQUITYCurrent

SEC Filing

Filed Jul 31, 2026Accepted Jul 31, 2026, 4:01 PM EDTCIK 1574565Accession 0001178913-26-003741
Share

Company context

Current securities

Recent company filings

  1. 6-K filingSep 15, 2026
  2. 6-K filingSep 4, 2026
  3. 6-K filingAug 27, 2026
  4. 4 filingAug 26, 2026
  5. 6-K filingAug 18, 2026

As-filed source

Primary evidence